These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19241948)

  • 1. Monitoring misuse of the WHO name and emblem in medicine promotion in India.
    Thawani V; Gharpure K
    Indian J Med Ethics; 2009; 6(1):10-4. PubMed ID: 19241948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of promotional advertisements of drugs in a medical journal: an ethics perspective.
    Nath S; Bhowmick S; Dutta T; Chowrasia VR; Bhattacharya S; Chatterjee RN; Sarkar M; Ram AK; Mukherjee PK
    Indian J Med Ethics; 2014; 11(4):237-41. PubMed ID: 25377037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supported and unsupported claims in medicinal drug advertisements in Indian medical journals.
    Dhanaraj E; Nigam A; Bagani S; Singh H; Tiwari P
    Indian J Med Ethics; 2011; 8(3):170-4. PubMed ID: 22106646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ethics of advertising strategies in the pharmaceutical industry.
    Reuter L
    Ethics Med; 2003; 19(3):171-5. PubMed ID: 14700051
    [No Abstract]   [Full Text] [Related]  

  • 5. Big bad pharma: an ethical analysis of physician-directed and consumer-directed marketing tactics.
    Connors AL
    Albany Law Rev; 2009 Sep; 73(1):243-82. PubMed ID: 20235401
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicines Information and the Regulation of the Promotion of Pharmaceuticals.
    Leonardo Alves T; Lexchin J; Mintzes B
    Sci Eng Ethics; 2019 Aug; 25(4):1167-1192. PubMed ID: 29721844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both sides of pharmaceutical promotion.
    Crigger NJ; Bennison LW
    Adv Nurse Pract; 2007 Jan; 15(1):61-2, 64-5, 74. PubMed ID: 19998677
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug advertisements in two dermatology journals: a critical comparison of IJDVL and JAAD.
    Gahalaut P; Chauhan S; Mishra N; Rastogi M; Thakur R
    Indian J Dermatol Venereol Leprol; 2014; 80(2):115-21. PubMed ID: 24685846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why self-regulation does not work: resolving prescription corruption caused by excessive gift-giving by pharmaceutical manufacturers.
    Mehta RS
    Food Drug Law J; 2008; 63(4):799-821. PubMed ID: 19593922
    [No Abstract]   [Full Text] [Related]  

  • 10. Ensuring ethical drug promotion--whose responsibility?
    Quick JD; Hogerzeil HV; Rägo L; Reggi V; de Joncheere K
    Lancet; 2003 Aug; 362(9385):747. PubMed ID: 12957107
    [No Abstract]   [Full Text] [Related]  

  • 11. The misuse of antibiotics.
    Levy SB; Star L; Kupferberg ED
    Med Ethics (Burlingt Mass); 2004; 11(1):5-8. PubMed ID: 15915579
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceuticals and medical devices: business practices.
    Jones TM
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-54. PubMed ID: 19297719
    [No Abstract]   [Full Text] [Related]  

  • 13. [The advertising of medicinal products to the public in Poland--legislative, ethical, health and social concerns].
    Cianciara D
    Przegl Epidemiol; 2004; 58(3):555-63. PubMed ID: 15730020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatry has effectively become a commodity that is being sold to the drug industry.
    Timimi S
    Ment Health Today; 2005 Jun; ():21. PubMed ID: 15999409
    [No Abstract]   [Full Text] [Related]  

  • 15. Logos: the emblem in the marketing wars.
    Chan SD
    Quintessence Int; 1994 Jul; 25(7):509-15. PubMed ID: 7991774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A proposal for the prevention of ethical problems related to drug promotion: a national network for drug information].
    Civaner M
    Turk Psikiyatri Derg; 2008; 19(3):310-7. PubMed ID: 18791884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The issue of applying marketing on the pharmaceutical market in Serbia.
    Dickov V; Dickov A; Martinović-Mitrović S
    Eur Rev Med Pharmacol Sci; 2011 Mar; 15(3):275-83. PubMed ID: 21528773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Industry-to-physician marketing and the cost of prescription drugs.
    Chiong W
    Am J Bioeth; 2003; 3(3):W28-W29. PubMed ID: 14594480
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug company influence.
    Mittman D
    Am J Nurs; 2009 Mar; 109(3):14; author reply 14. PubMed ID: 19240469
    [No Abstract]   [Full Text] [Related]  

  • 20. The politics and strategy of industry self-regulation: the pharmaceutical industry's principles for ethical direct-to-consumer advertising as a deceptive blocking strategy.
    Arnold DG; Oakley JL
    J Health Polit Policy Law; 2013 Jun; 38(3):505-44. PubMed ID: 23418365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.